STAT1 and juvenile dermatomyositis: The remaining four patients had the following autoimmune interferonopathies: 2/4 systemic lupus erythematosus (SLE), 1/4 juvenile dermatomyositis (JDM), 1/4 autoimmune hepatitis with a detected gain-of-function mutation in STAT1 (Table 2).